Zhou, L.; Zhao, J.; Han, M.; Ma, A.; Yang, S.; Zeng, Y.; Cheng, J.
Aspartate Reduces Liver Inflammation and Fibrosis by Suppressing the NLRP3 Inflammasome Pathway via Upregulating NS3TP1 Expression. J. Pers. Med. 2023, 13, 386.
https://doi.org/10.3390/jpm13030386
AMA Style
Zhou L, Zhao J, Han M, Ma A, Yang S, Zeng Y, Cheng J.
Aspartate Reduces Liver Inflammation and Fibrosis by Suppressing the NLRP3 Inflammasome Pathway via Upregulating NS3TP1 Expression. Journal of Personalized Medicine. 2023; 13(3):386.
https://doi.org/10.3390/jpm13030386
Chicago/Turabian Style
Zhou, Li, Jing Zhao, Ming Han, Anlin Ma, Song Yang, Yilan Zeng, and Jun Cheng.
2023. "Aspartate Reduces Liver Inflammation and Fibrosis by Suppressing the NLRP3 Inflammasome Pathway via Upregulating NS3TP1 Expression" Journal of Personalized Medicine 13, no. 3: 386.
https://doi.org/10.3390/jpm13030386
APA Style
Zhou, L., Zhao, J., Han, M., Ma, A., Yang, S., Zeng, Y., & Cheng, J.
(2023). Aspartate Reduces Liver Inflammation and Fibrosis by Suppressing the NLRP3 Inflammasome Pathway via Upregulating NS3TP1 Expression. Journal of Personalized Medicine, 13(3), 386.
https://doi.org/10.3390/jpm13030386